|
AU6340998A
|
|
Permuted hemoglobin-like proteins
|
|
AU4990697A
|
|
Methods of reducing the levels of protoporphyrin ix in recombinant hemoglobin preparations
|
|
AU4149597A
|
|
Production of heme and recombinant hemoproteins
|
|
AU3904497A
|
|
Methods of controlling beta dimer formation in hemoglobin
|
|
WO9719956A1
|
|
Method for control of functionality during cross-linking of hemoglobins
|
|
AU6489996A
|
|
Methods for increasing protein expression
|
|
CA2207775A1
|
|
Method for facilitating autologous blood donation and treating oxygen debt
|
|
US5844090A
|
|
Modified hemoglobin-like compounds
|
|
CA2203133A1
|
|
Purification of hemoglobin
|
|
US6242417B1
|
|
Stabilized compositions containing hemoglobin
|
|
AU1054995A
|
|
Method for the rapid removal of protoporphyrin IX from protoporphyrin IX containing solutions of hemoglobin
|
|
AU7194694A
|
|
Treatment of adverse effects associated with administration of extracellular hemoglobin
|
|
US5631219A
|
|
Method of stimulating hematopoiesis with hemoglobin
|
|
US5717058A
|
|
Peptide inhibitors of tax-dependent transcription
|
|
US6140071A
|
|
Proteins with mutations to decrease N-terminal methylation
|
|
US5449759A
|
|
Hemoglobins with intersubunit desulfide bonds
|
|
US5665869A
|
|
Method for the rapid removal of protoporphyrin from protoporphyrin IX-containing solutions of hemoglobin
|
|
US5578564A
|
|
Nickel-free hemoglobin and methods for producing such hemoglobin
|
|
IL103681D0
|
|
Multimeric hemoglobins
|
|
IL103676D0
|
|
Pharmaceutical compositions containing hemoglobins as drug delivery agents and methods for the preparation thereof
|
